glp-1 for alzheimer's Glucagon like peptide-1 (GLP-1) likes disease Neuroprotective Actions of Glucagon-Like Peptide-1
Description
Endogenous GLP-1 has a plasma half-life of under two minutes
Now, promising new research suggests that the same class of GLP-1 medications making headlines for weight loss and blood sugar control may also bring real relief to women who struggle with chronic migraines
Efficacy and safety of maintenance ustekinumab for ulcerative colitis through 3 Years: UNIFI Long-term extension
ArticlePubMedPMC 41
Pre-existing spinal conditions may also become more apparent or symptomatic during the weight loss process, though this represents coincidental timing rather than causation
